Canaccord Genuity Maintains Buy on Insulet, Raises Price Target to $269
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity has maintained its Buy rating on Insulet (NASDAQ:PODD) and raised the price target from $236 to $269, indicating a positive outlook for the company's stock.
September 25, 2024 | 2:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity has increased its price target for Insulet from $236 to $269, maintaining a Buy rating. This suggests confidence in Insulet's future performance and could positively influence investor sentiment.
The increase in price target from $236 to $269 by Canaccord Genuity, along with the maintained Buy rating, indicates a strong positive outlook for Insulet. This is likely to boost investor confidence and could lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100